eBioscience Purchase Nudges Affymetrix Q2 Revenues up 3 Percent
August 01, 2012
eBioscience Purchase Nudges Affymetrix Q2 Revenues up 3 Percent
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Despite Continued Genotyping Growth, Weak Expression Sales Force Affymetrix to Suspend Guidance
May 7, 2013 / BioArray News - Affymetrix Cites Challenging Quarter as Results Fall Short of Expectations
May 1, 2013 / GenomeWeb Daily News - Affymetrix's Q1 Revenues to Miss Wall Street Estimates
April 9, 2013 / GenomeWeb Daily News - Affymetrix's eBio Business Moving FlowCytomix Assays to Luminex Platform, Planning New Product Combinations
April 2, 2013 / BioArray News - Affymetrix, Life Tech Resolve eBioscience-Related Infringement Suits
February 19, 2013 / BioArray News